2016-09-14 |
2016-09-13 |
K
Kauf
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
75.000
+1.7%
1,75
131.250 USD
|
75.000
+1.7%
|
1,75
|
131.250 USD
|
|
2016-09-12 |
2016-09-12 |
K
Kauf
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
76.000
+1.8%
1,70
129.200 USD
|
76.000
+1.8%
|
1,70
|
129.200 USD
|
|
2016-09-12 |
2016-09-12 |
K
Kauf
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
100.000
+2.4%
1,70
169.600 USD
|
100.000
+2.4%
|
1,70
|
169.600 USD
|
|
2016-09-12 |
2016-09-09 |
K
Kauf
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
100.000
+2.5%
1,60
159.500 USD
|
100.000
+2.5%
|
1,60
|
159.500 USD
|
|
2015-11-13 |
2015-11-11 |
K
Kauf
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
35.000
+0.9%
10,96
383.600 USD
|
35.000
+0.9%
|
10,96
|
383.600 USD
|
|
2015-11-13 |
2015-11-11 |
K
Kauf
|
Broadfin Healthcare Master Fund Ltd
Large shareholder
|
5.100
+0.1%
10,99
56.049 USD
|
5.100
+0.1%
|
10,99
|
56.049 USD
|
|
2014-08-20 |
2014-08-19 |
K
Kauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
1.150
+13.8%
30,64
35.236 USD
|
1.150
+13.8%
|
30,64
|
35.236 USD
|
|
2014-07-31 |
2014-07-31 |
K
Kauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.300
+3.0%
34,37
79.051 USD
|
2.300
+3.0%
|
34,37
|
79.051 USD
|
|
2014-07-31 |
2014-07-31 |
K
Kauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
7.700
+11.1%
33,44
257.488 USD
|
7.700
+11.1%
|
33,44
|
257.488 USD
|
|
2014-06-04 |
2014-06-03 |
K
Kauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
10.000
+16.8%
30,12
301.200 USD
|
10.000
+16.8%
|
30,12
|
301.200 USD
|
|
2014-05-27 |
2014-05-27 |
K
Kauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
10.000
+20.2%
31,59
315.900 USD
|
10.000
+20.2%
|
31,59
|
315.900 USD
|
|
2014-05-21 |
2014-05-20 |
K
Kauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
10.000
+30.3%
30,53
305.300 USD
|
10.000
+30.3%
|
30,53
|
305.300 USD
|
|
2014-05-09 |
2014-05-08 |
K
Kauf
|
VANLENT ANNE
Nicht geschäftsführender Verwaltungsratsmitglied
|
52
+1.3%
35,29
1.835 USD
|
52
+1.3%
|
35,29
|
1.835 USD
|
|
2014-05-09 |
2014-05-08 |
K
Kauf
|
VANLENT ANNE
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.948
+97.4%
34,33
66.875 USD
|
1.948
+97.4%
|
34,33
|
66.875 USD
|
|
2014-05-09 |
2014-05-08 |
K
Kauf
|
VANLENT ANNE
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.000
+inf%
33,20
66.400 USD
|
2.000
+inf%
|
33,20
|
66.400 USD
|
|
2014-05-08 |
2014-05-08 |
K
Kauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
30.000
+1000.0%
35,31
1.059.300 USD
|
30.000
+1000.0%
|
35,31
|
1.059.300 USD
|
|
2014-05-01 |
2014-04-30 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
1.171
-100.0%
43,90
51.407 USD
|
1.171
-100.0%
|
43,90
|
51.407 USD
|
|
2014-05-01 |
2014-04-30 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
1.079
-48.0%
43,18
46.591 USD
|
1.079
-48.0%
|
43,18
|
46.591 USD
|
|
2014-04-02 |
2014-03-31 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
100
-100.0%
47,20
4.720 USD
|
100
-100.0%
|
47,20
|
4.720 USD
|
|
2014-04-02 |
2014-03-31 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
1.001
-90.9%
46,51
46.557 USD
|
1.001
-90.9%
|
46,51
|
46.557 USD
|
|
2014-04-02 |
2014-03-31 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
1.149
-51.1%
45,84
52.670 USD
|
1.149
-51.1%
|
45,84
|
52.670 USD
|
|
2014-03-18 |
2014-03-14 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
800
-100.0%
51,98
41.584 USD
|
800
-100.0%
|
51,98
|
41.584 USD
|
|
2014-03-18 |
2014-03-14 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
900
-52.9%
51,31
46.179 USD
|
900
-52.9%
|
51,31
|
46.179 USD
|
|
2014-03-18 |
2014-03-14 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
300
-15.0%
49,69
14.907 USD
|
300
-15.0%
|
49,69
|
14.907 USD
|
|
2014-02-18 |
2014-02-14 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
500
-100.0%
64,52
32.260 USD
|
500
-100.0%
|
64,52
|
32.260 USD
|
|
2014-02-18 |
2014-02-14 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
1.500
-75.0%
63,14
94.710 USD
|
1.500
-75.0%
|
63,14
|
94.710 USD
|
|
2014-02-12 |
2014-02-11 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
2.250
-100.0%
67,00
150.750 USD
|
2.250
-100.0%
|
67,00
|
150.750 USD
|
|
2014-02-12 |
2014-02-10 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
486
-7.7%
64,69
31.439 USD
|
486
-7.7%
|
64,69
|
31.439 USD
|
|
2014-02-12 |
2014-02-10 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
900
-12.4%
63,72
57.348 USD
|
900
-12.4%
|
63,72
|
57.348 USD
|
|
2014-02-12 |
2014-02-10 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
2.814
-28.0%
62,94
177.113 USD
|
2.814
-28.0%
|
62,94
|
177.113 USD
|
|
2014-02-12 |
2014-02-10 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
3.300
-24.7%
61,71
203.643 USD
|
3.300
-24.7%
|
61,71
|
203.643 USD
|
|
2014-01-21 |
2014-01-16 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
100
-100.0%
59,51
5.951 USD
|
100
-100.0%
|
59,51
|
5.951 USD
|
|
2014-01-21 |
2014-01-16 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
1.900
-95.0%
58,59
111.318 USD
|
1.900
-95.0%
|
58,59
|
111.318 USD
|
|
2014-01-06 |
2014-01-02 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
600
-100.0%
71,41
42.847 USD
|
600
-100.0%
|
71,41
|
42.847 USD
|
|
2014-01-06 |
2014-01-02 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
400
-40.0%
70,22
28.087 USD
|
400
-40.0%
|
70,22
|
28.087 USD
|
|
2014-01-06 |
2014-01-02 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
1.350
-100.0%
71,42
96.414 USD
|
1.350
-100.0%
|
71,42
|
96.414 USD
|
|
2014-01-06 |
2014-01-02 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
900
-40.0%
70,65
63.584 USD
|
900
-40.0%
|
70,65
|
63.584 USD
|
|
2013-12-17 |
2013-12-16 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
200
-100.0%
67,38
13.476 USD
|
200
-100.0%
|
67,38
|
13.476 USD
|
|
2013-12-17 |
2013-12-16 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
1.800
-90.0%
66,23
119.211 USD
|
1.800
-90.0%
|
66,23
|
119.211 USD
|
|
2013-12-04 |
2013-12-02 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
700
-100.0%
71,10
49.769 USD
|
700
-100.0%
|
71,10
|
49.769 USD
|
|
2013-12-04 |
2013-12-02 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
1.550
-68.9%
70,10
108.654 USD
|
1.550
-68.9%
|
70,10
|
108.654 USD
|
|
2013-12-04 |
2013-12-02 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
600
-100.0%
71,20
42.718 USD
|
600
-100.0%
|
71,20
|
42.718 USD
|
|
2013-12-04 |
2013-12-02 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
2.400
-80.0%
70,23
168.549 USD
|
2.400
-80.0%
|
70,23
|
168.549 USD
|
|
2013-11-19 |
2013-11-15 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
500
-100.0%
77,63
38.817 USD
|
500
-100.0%
|
77,63
|
38.817 USD
|
|
2013-11-19 |
2013-11-15 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
1.011
-66.9%
75,89
76.726 USD
|
1.011
-66.9%
|
75,89
|
76.726 USD
|
|
2013-11-19 |
2013-11-15 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
489
-24.4%
74,93
36.639 USD
|
489
-24.4%
|
74,93
|
36.639 USD
|
|
2013-11-13 |
2013-11-11 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
1.800
-37.5%
80,03
144.057 USD
|
1.800
-37.5%
|
80,03
|
144.057 USD
|
|
2013-11-13 |
2013-11-11 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
4.478
-48.3%
79,34
355.300 USD
|
4.478
-48.3%
|
79,34
|
355.300 USD
|
|
2013-11-13 |
2013-11-11 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
622
-6.3%
78,38
48.755 USD
|
622
-6.3%
|
78,38
|
48.755 USD
|
|
2013-11-13 |
2013-11-11 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
200
-2.0%
76,14
15.228 USD
|
200
-2.0%
|
76,14
|
15.228 USD
|
|
2013-11-13 |
2013-11-11 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
200
-1.9%
74,43
14.886 USD
|
200
-1.9%
|
74,43
|
14.886 USD
|
|
2013-11-13 |
2013-11-11 |
GV
Geplanter Verkauf
|
Fitzpatrick Mark J.
Chief Financial Officer
Führungsperson
|
200
-1.9%
73,01
14.603 USD
|
200
-1.9%
|
73,01
|
14.603 USD
|
|
2013-11-05 |
2013-11-01 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
100
-100.0%
84,34
8.434 USD
|
100
-100.0%
|
84,34
|
8.434 USD
|
|
2013-11-05 |
2013-11-01 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
2.000
-95.2%
83,59
167.180 USD
|
2.000
-95.2%
|
83,59
|
167.180 USD
|
|
2013-11-05 |
2013-11-01 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
1.400
-40.0%
82,76
115.867 USD
|
1.400
-40.0%
|
82,76
|
115.867 USD
|
|
2013-11-05 |
2013-11-01 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
400
-100.0%
83,99
33.597 USD
|
400
-100.0%
|
83,99
|
33.597 USD
|
|
2013-11-05 |
2013-11-01 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
1.550
-79.5%
83,22
128.994 USD
|
1.550
-79.5%
|
83,22
|
128.994 USD
|
|
2013-11-05 |
2013-11-01 |
GV
Geplanter Verkauf
|
Fraser Craig
Pres., US/Int. Comm. & Manuf.
Führungsperson
|
300
-13.3%
82,28
24.684 USD
|
300
-13.3%
|
82,28
|
24.684 USD
|
|
2013-11-05 |
2013-11-01 |
GV
Geplanter Verkauf
|
Carter Martha J.
Chief Regulatory Officer & SVP
Führungsperson
|
5.000
-76.9%
82,81
414.051 USD
|
5.000
-76.9%
|
82,81
|
414.051 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.200
-0.6%
99,18
119.016 USD
|
1.200
-0.6%
|
99,18
|
119.016 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
300
-0.2%
95,90
28.770 USD
|
300
-0.2%
|
95,90
|
28.770 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
200
-0.1%
94,25
18.850 USD
|
200
-0.1%
|
94,25
|
18.850 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
400
-0.2%
93,00
37.200 USD
|
400
-0.2%
|
93,00
|
37.200 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
700
-0.4%
92,03
64.421 USD
|
700
-0.4%
|
92,03
|
64.421 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.500
-1.2%
91,21
228.031 USD
|
2.500
-1.2%
|
91,21
|
228.031 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.700
-1.3%
89,85
242.592 USD
|
2.700
-1.3%
|
89,85
|
242.592 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
3.800
-1.8%
89,01
338.243 USD
|
3.800
-1.8%
|
89,01
|
338.243 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
6.019
-2.8%
87,83
528.619 USD
|
6.019
-2.8%
|
87,83
|
528.619 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
10.000
-4.5%
87,08
870.752 USD
|
10.000
-4.5%
|
87,08
|
870.752 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.314
-1.0%
85,94
198.860 USD
|
2.314
-1.0%
|
85,94
|
198.860 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
7.067
-3.0%
85,00
600.689 USD
|
7.067
-3.0%
|
85,00
|
600.689 USD
|
|
2013-10-31 |
2013-10-30 |
GV
Geplanter Verkauf
|
Beer Marc D
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.800
-1.2%
84,15
235.621 USD
|
2.800
-1.2%
|
84,15
|
235.621 USD
|
|
2013-10-31 |
2013-10-29 |
GV
Geplanter Verkauf
|
SMITH SANDFORD D
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.502
-100.0%
95,00
237.690 USD
|
2.502
-100.0%
|
95,00
|
237.690 USD
|
|
2013-10-16 |
2013-10-15 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
1.000
-100.0%
80,71
80.709 USD
|
1.000
-100.0%
|
80,71
|
80.709 USD
|
|
2013-10-16 |
2013-10-15 |
GV
Geplanter Verkauf
|
Sumeray Mark
Chief Medical Officer
Führungsperson
|
1.000
-50.0%
79,95
79.950 USD
|
1.000
-50.0%
|
79,95
|
79.950 USD
|
|